Major strength of this study is the coexistence of data on plasma and tissue DPP4 in a large population of metabolically characterized individuals with different grade of obesity, metabolic impairment and NAFLD/NASH. Here, DPP4 is linked to metabolic dysfunction-associated steatohepatitis.